Cost-utility analysis of interventions to reduce the burden of cervical cancer in Israel.
Using World health Organization, CHOosing Interventions that are Cost Effective (WHO-CHOICE) methodology, cost-utility ratios were calculated for various interventions (Papanicolaou [Pap] smear, human papillomavirus [HPV]-DNA testing, visual inspection with acetic acid [VIA] and vaccination against HPV) at various frequencies to reduce the burden of cervical cancer and condyloma (in the case of the HPV vaccination) in Israel, which has a low prevalence of cervical cancer. All of the screening and/or vaccine interventions were very cost-effective. Attempts should be made to raise compliancy with Pap smears from the current opportunistic 12.1% per annum to screen everyone aged 20-64 once every 5 years in combination with HPV-DNA testing for persons aged 30-64 both before and/or after HPV vaccination is introduced. This article forms part of a regional report entitled "Comprehensive Control of HPV Infections and Related Diseases in Israel" Vaccine Volume 31, Supplement 8, 2013. Updates of the progress in the field are presented in a separate monograph entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012.
Medical Technology Assessment Sector, Ministry of Health, Ben Tbai 2, Jerusalem, Israel. Electronic address: jd.bailey@elsevier.com.
Gary M
GM
Ginsberg
D000293:Adolescent; D000328:Adult; D002648:Child; D003362:Cost-Benefit Analysis; D055088:Early Detection of Cancer / Q000191:economics* / Q000379:methods; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007557:Israel / Q000453:epidemiology; D008875:Middle Aged; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000191:economics / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000453:epidemiology / Q000517:prevention & control*; D014611:Vaccination / Q000191:economics / Q000379:methods*; D055815:Young Adult
D053918:Papillomavirus Vaccines
Cervical Cancer; Cost-Utility Analysis; HPV; Israel; Screening; Vaccination